Implications of chirality and geometric isomerism in some psychoactive drugs and their metabolites
- 1 January 1989
- Vol. 1 (2) , 99-120
- https://doi.org/10.1002/chir.530010204
Abstract
Many drugs contain a chiral centre, or such a centre is introduced during metabolism of the drug in man and in animals. If a single chiral centre is present, the drug will normally exist as a mixture of two enantiomers, of which one may have quite different pharmacologic and/or toxic effects than the other. Chiral drugs that are used in psychiatry, and some other pharmacologically related drugs are identified, and the implications of the presence of one or two chiral centres in these drugs are discussed. Differences in pharmacologic properties of drug and metabolite enantiomers are identified and discussed. Also reviewed are the properties of some drugs used in psychiatry that both are chiral and display geometric isomerism.Keywords
This publication has 73 references indexed in Scilit:
- The absolute configurations and pharmacological activities of the optical isomers of fluoxetine, a selective serotonin-uptake inhibitorJournal of Medicinal Chemistry, 1988
- Separation of the Enantiomers of Pheneturide in Serum by High-Performance Liquid ChromatographyJournal of Liquid Chromatography, 1988
- Effects of tranylcypromine enantiomers on monoamine uptake and release and imipramine bindingJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1986
- Importance of Drug Enantiomers in Clinical PharmacologyDrugs, 1985
- The Role of Metabolite-Specific Antibodies in Nomifensine-Dependent Immune Hemolytic AnemiaNew England Journal of Medicine, 1985
- Active Drug MetabolitesClinical Pharmacokinetics, 1985
- Defective Oxidation of DrugsClinical Pharmacokinetics, 1982
- Pronounced inhibition of noradrenaline uptake by 10-hydroxymetabolites of nortriptylineLife Sciences, 1979
- NomifensineDrugs, 1979
- Doxepin Up-to-DateDrugs, 1977